SL
Insider
Sr One Capital Management, Llc
10% ownerSr One Capital Management, Llc (10% owner) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (3 purchases, 0 sales), most often in ADARx Pharmaceuticals, Inc. (ADRX). Across 3 priced purchase filings, the average 21-session return was -2.6% from execution and -3.5% from disclosure (delay-adjusted; derived). The largest single filing was $27.2M of ADRX (1,600,000 sh across 3 lots, as filed), executed Sep 28. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-2.6%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-3.5%
same 3 filings, from disclosure
Filings, ttm
3
3 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$47.2M
shares × price, as filed
Last traded
Sep 28
Filed Sep 29
Median ADV $46.2M across their filed names
Open performance→Volume by month
Buys $49.6M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ADRXRecent filings
ADRXPURCHASE
ADARx Pharmaceuticals, Inc.
View filing →
$27.2M1,600,000 sh across 3 lots
Exec Sep 28
Filed Sep 29 · 9:45 PM ET ODTXPURCHASE Odyssey Therapeutics, Inc. View filing → $10.0M
555,555 sh across 3 lots
Exec May 11
Filed May 11 · 9:11 PM ET AVLNPURCHASE Avalyn Pharma Inc. View filing → $10.0M
555,555 sh across 2 lots
Exec May 1
Filed May 1 · 6:46 PM ET ZBIOPURCHASE Zenas BioPharma, Inc. View filing → $2.4M
126,315 sh across 2 lots
Exec Oct 9 2025
Filed Oct 14 2025 · 5:14 PM ET